Evidence map›Paper›PMID 31997506›Full record

ArticleThe FEBS journal2020

Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.

Shuwei Zhang, Chen Li, Junchao Liu, Fengxue Geng, Xiaoting Shi, Qian Li, Ze Lu, Yaping Pan

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shuwei ZhangDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.ORCID 0000-0002-6296-7239
Chen LiDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Junchao LiuDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Fengxue GengDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Xiaoting ShiDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Qian LiLiaoning Provincial Key Laboratory of Oral Diseases, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Ze LuDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Yaping PanDepartment of Periodontics, School and Hospital of Stomatology, China Medical University, Shenyang, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fusobacterium nucleatum, an anaerobic oral opportunistic pathogen associated with periodontitis, has been considered to be associated with the development of oral squamous cell carcinoma (OSCC). However, the initial host molecular alterations induced by F. nucleatum infection which may promote predisposition to malignant transformation through epithelial-mesenchymal transition (EMT) have not yet been clarified. In the present study, we monitored the ability of F. nucleatum to induce EMT-associated features, and our results showed that F. nucleatum infection promoted cell migration in either noncancerous human immortalized oral epithelial cells (HIOECs) or the two OSCC cell lines SCC-9 and HSC-4, but did not accelerate cell proliferation or cell cycle progression. Mesenchymal markers, including N-cadherin, Vimentin, and SNAI1, were upregulated, while E-cadherin was decreased and was observed to translocate to the cytoplasm. Furthermore, FadA adhesin and heat-inactivated F. nucleatum were found to cause a similar effect as the viable bacterial cells. The upregulated lncRNA MIR4435-2HG identified by the high-throughput sequencing was demonstrated to negatively regulate the expression of miR-296-5p, which was downregulated in F. nucleatum-infected HIOECs and SCC-9 cells. The binding of MIR4435-2HG and miR-296-5p was validated via a dual-luciferase reporter assay. Additionally, knockdown of MIR4435-2HG with siRNA leads to a decrease in SNAI1 expression, while miR-296-5p could further negatively and indirectly regulate SNAI1 expression via Akt2. Therefore, our study demonstrated that F. nucleatum infection could trigger EMT via lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway, and EMT process may be a probable link between F. nucleatum infection and initiation of oral epithelial carcinomas.

Indexed as

Gene Expression Regulation, NeoplasticCadherinsCarcinoma, Squamous CellCell Line, TumorEpithelial-Mesenchymal TransitionFusobacterium InfectionsFusobacterium nucleatumHost-Pathogen InteractionsHumansMicroRNAsMouth NeoplasmsProto-Oncogene Proteins c-aktRNA, Long NoncodingSignal TransductionSnail Family Transcription FactorsAKT2 protein, humanCadherinsMicroRNAsMIR4435-2HG long non-coding RNA, humanMIRN296 microRNA, humanProto-Oncogene Proteins c-aktRNA, Long NoncodingSNAI1 protein, humanSnail Family Transcription FactorsE-cadherinepithelial-mesenchymal transitionFusobacterium nucleatumMIR4435-2HGSNAIL1

Identifiers

PMID31997506
PMCPMC7540502
OpenAlexW3003499510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.